Suppr超能文献

重复低剂量激发试验分析

Analysis of repeated low-dose challenge studies.

作者信息

Nolen Tracy L, Hudgens Michael G, Senb Pranab K, Koch Gary G

机构信息

RTI International, The Research Triangle Park, NC, 27709, U.S.A.

出版信息

Stat Med. 2015 May 30;34(12):1981-92. doi: 10.1002/sim.6462. Epub 2015 Mar 9.

Abstract

Preclinical evaluation of candidate human immunodeficiency virus (HIV) vaccines entails challenge studies whereby non-human primates such as macaques are vaccinated with either an active or control vaccine and then challenged (exposed) with a simian-version of HIV. Repeated low-dose challenge (RLC) studies in which each macaque is challenged multiple times (either until infection or some maximum number of challenges is reached) are becoming more common in an effort to mimic natural exposure to HIV in humans. Statistical methods typically employed for the testing for a vaccine effect in RLC studies include a modified version of Fisher's exact test as well as large sample approaches such as the usual log-rank test. Unfortunately, these methods are not guaranteed to provide a valid test for the effect of vaccination. On the other hand, valid tests for vaccine effect such as the exact log-rank test may not be easy to implement using software available to many researchers. This paper details which statistical approaches are appropriate for the analysis of RLC studies, and how to implement these methods easily in SAS or R.

摘要

候选人类免疫缺陷病毒(HIV)疫苗的临床前评估需要进行攻毒研究,即对猕猴等非人灵长类动物接种活性疫苗或对照疫苗,然后用猿猴版本的HIV进行攻毒(暴露)。重复低剂量攻毒(RLC)研究中,每只猕猴接受多次攻毒(要么直到感染,要么达到最大攻毒次数),这种研究正变得越来越普遍,旨在模拟人类自然接触HIV的情况。RLC研究中通常用于检验疫苗效果的统计方法包括费舍尔精确检验的修正版本以及大样本方法,如常用的对数秩检验。不幸的是,这些方法并不能保证为疫苗接种效果提供有效的检验。另一方面,像精确对数秩检验这样的有效疫苗效果检验,使用许多研究人员可用的软件可能不容易实现。本文详细介绍了哪些统计方法适用于RLC研究的分析,以及如何在SAS或R中轻松实现这些方法。

相似文献

1
Analysis of repeated low-dose challenge studies.
Stat Med. 2015 May 30;34(12):1981-92. doi: 10.1002/sim.6462. Epub 2015 Mar 9.
2
Surrogates of protection in repeated low-dose challenge experiments.
Stat Med. 2015 May 10;34(10):1747-60. doi: 10.1002/sim.6436. Epub 2015 Jan 28.
3
Timing of retroviral infection influences anamnestic immune response in vaccinated primates.
Viral Immunol. 2005;18(4):689-94. doi: 10.1089/vim.2005.18.689.
4
AIDS vaccines show promise in primates.
Clin Infect Dis. 2001 Oct 1;33(7):i-ii.
8
A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
J Virol. 2005 Mar;79(6):3419-28. doi: 10.1128/JVI.79.6.3419-3428.2005.

引用本文的文献

2
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge.
PLoS Pathog. 2020 Sep 3;16(9):e1008764. doi: 10.1371/journal.ppat.1008764. eCollection 2020 Sep.
3
Estimating the basic reproduction number of a pathogen in a single host when only a single founder successfully infects.
PLoS One. 2020 Jan 10;15(1):e0227127. doi: 10.1371/journal.pone.0227127. eCollection 2020.
5
Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques.
mSphere. 2018 Jan 10;3(1). doi: 10.1128/mSphere.00505-17. eCollection 2018 Jan-Feb.
7
A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):363-71. doi: 10.1097/QAI.0000000000000975.
9
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences.
PLoS Pathog. 2016 Feb 5;12(2):e1005431. doi: 10.1371/journal.ppat.1005431. eCollection 2016 Feb.

本文引用的文献

1
Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspective.
Curr Opin HIV AIDS. 2010 Sep;5(5):377-85. doi: 10.1097/COH.0b013e32833d2e19.
5
Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments.
J Infect Dis. 2009 Aug 15;200(4):609-13. doi: 10.1086/600891.
6
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques.
Nat Med. 2009 Aug;15(8):951-4. doi: 10.1038/nm.1974. Epub 2009 Jun 7.
7
Assessing vaccine effects in repeated low-dose challenge experiments.
Biometrics. 2009 Dec;65(4):1223-32. doi: 10.1111/j.1541-0420.2009.01189.x.
8
Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.
Lancet Infect Dis. 2009 Feb;9(2):118-29. doi: 10.1016/S1473-3099(09)70021-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验